Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Opiant and Sanofi sign licensing deal for drinabant
Opiant Pharmaceuticals has signed a licensing agreement with Sanofi for the development and commercialisation of drinabant across the globe for the treatment of acute cannabinoid overdose (ACO).
Production & Sales
-
27 Dec 2018
-
24 Dec 2018
Lupin awards MALT1’s licensing rights to AbbVie
Indian pharmaceutical company Lupin has awarded the licensing rights of its Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT1) programme to AbbVie.
-
20 Dec 2018
Taisho offers to buy BMS’ UPSA consumer health business for $1.6bn
Taisho Pharmaceutical has offered $1.6bn to acquire UPSA consumer health business from Bristol-Myers Squibb (BMS).
-
20 Dec 2018
Pfizer, GSK to create $13bn consumer healthcare joint venture
Pfizer and the UK-based GlaxoSmithKline (GSK) have agreed to merge their respective consumer healthcare businesses into a new joint venture (JV), which will be majority owned by the latter.
-
12 Dec 2018
Circassia to acquire full US rights of AstraZeneca’s COPD treatment Tudorza
Circassia Pharmaceuticals is set to exercise an option to purchase full US commercial rights of chronic obstructive pulmonary disease treatment, Tudorza (aclidinium), from AstraZeneca.
-
07 Dec 2018
AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
AstraZeneca has completed its $350m sale of its rights to asthma drug Alvesco (ciclesonide) and nasal sprays Omnaris and Zetonna (ciclesonide) to Switzerland-based Covis Pharma.
-
06 Dec 2018
Tris Pharma recalls infants’ liquid Ibuprofen in US
Tris Pharma has voluntarily recalled three lots of Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, to the retail level in the US.
-
03 Dec 2018
Crown Laboratories buys select OTC consumer healthcare brands from GSK
Crown Laboratories, a privately held, fully integrated global skin care company, has acquired North American distribution rights of five OTC consumer brands from GlaxoSmithKline (GSK).
-
23 Nov 2018
GSK, Kyowa Hakko Kirin to commercialize anemia drug daprodustat in Japan
British drugmaker GlaxoSmithKline (GSK) has entered into a collaboration with Kyowa Hakko Kirin to commercialize daprodustat in Japan.
-
22 Nov 2018
Cambrex to acquire contract drug developer Avista Pharma for $252m
Life sciences company Cambrex has agreed to acquire Avista Pharma Solutions, a North Carolina-based contract development, manufacturing, and testing organization, for about $252m.